Markets

Brazilian antitrust watchdog bars healthcare firm Hapvida's deal

Credit: REUTERS/Ricardo Moraes

Brazilian antitrust watchdog CADE has blocked a deal announced by healthcare company Hapvida Participações to by health insurer Plamed.

By Alberto Alerigi

SAO PAULO, Nov 25 (Reuters) - Brazilian antitrust watchdog CADE has blocked a deal announced by healthcare company Hapvida Participações HAPV3.SA to by health insurer Plamed.

CADE´s technical body had given an earlier approval to the deal demanding the sale of part of its 26,000 clients portfolio, but the councillors voted to bar the deal completely. In a securities filing late on Wednesday, the company said it was discussing with its advisors the alternatives for the deal.

(Reporting by Alberto Alerigi Jr.; Writing by Tatiana Bautzer; Editing by Edmund Blair)

((tatiana.bautzer@tr.com; Tel: +55-11-5644-7756; Mob: +55-119-4210-4173; Reuters Messaging: tatiana.bautzer.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

US Markets

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More